Article
Assessment of bleeding risk in patients with coronary artery disease on dual antiplatelet therapy. A systematic review.
Thrombosis and haemostasis - 1 Jan 2016
Vries Minka J A, van der Meijden Paola E J, Henskens Yvonne M C, ten Cate-Hoek Arina J, ten Cate Hugo
Abstract excerpt
Patients with coronary artery disease are usually treated with dual antiplatelet therapy (DAPT) after percutaneous coronary intervention. Patients on DAPT are at risk of both ischaemic and bleeding events. Although side-lined for a long time, real-life studies have shown that both the incidence and the associated morbidity and mortality of out-of-hospital bleeding are high. This indicates that prevention of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.